GYRO vs WELL vs GMRE vs VTR

For growth investors, Welltower Inc.

(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus -1. 8% for Global Medical REIT Inc. (GMRE). Global Medical REIT Inc. (GMRE) offers the better valuation at 115. 3x trailing P/E (595. 7x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Global Medical REIT Inc.

(GMRE) is the cheapest at 115. 3x versus Ventas, Inc. at 160. 7x. On forward P/E, Welltower Inc. is actually cheaper at 78. 9x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Welltower Inc.

(WELL) delivered a total return of +212. 6%, compared to -40. 5% for Gyrodyne, LLC (GYRO). Over 10 years, the gap is even starker: GMRE returned +308. 1% versus GYRO's -30. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Ventas, Inc.

(VTR) is the lower-risk stock at 0. 01β versus Global Medical REIT Inc. 's 0. 48β — meaning GMRE is approximately 4957% more volatile than VTR relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 118% for Global Medical REIT Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Welltower Inc.

(WELL) is pulling ahead at 35. 8% versus -1. 8% for Global Medical REIT Inc. (GMRE). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -94. 6% for Global Medical REIT Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Welltower Inc.

(WELL) is the more profitable company, earning 8. 8% net margin versus 0. 0% for Gyrodyne, LLC — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GMRE leads at 23. 6% versus -1. 2% for GYRO. At the gross margin level — before operating expenses — GYRO leads at 99. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Welltower Inc.

(WELL) trades at 78. 9x forward P/E versus 595. 7x for Global Medical REIT Inc. — 516. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GMRE: 11. 9% to $40. 00.

In this comparison, GMRE (63.

5% yield), VTR (2. 1% yield), WELL (1. 3% yield) pay a dividend. GYRO does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Ventas, Inc.

(VTR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 01), 2. 1% yield). Both have compounded well over 10 years (VTR: +67. 4%, GYRO: -30. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: GYRO is a small-cap quality compounder stock; WELL is a mid-cap high-growth stock; GMRE is a small-cap income-oriented stock; VTR is a mid-cap high-growth stock. WELL, GMRE, VTR pay a dividend while GYRO does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.